Director, Corporate Finance
Lexeo Therapeutics
About this role
The Director, Corporate Finance at Lexeo Therapeutics oversees financial planning, analysis, and capital allocation, supporting strategic objectives and operational success. The role involves collaboration with senior management to ensure financial discipline and resource planning in a biopharmaceutical environment, leveraging industry experience to enable financial rigor and decision support.
Skills
Qualifications
About Lexeo Therapeutics
lexeotx.comLexeo Therapeutics is a New York City–based, clinical-stage genetic medicine company focused on reshaping heart health. It develops precision genetic therapies that target the underlying genetic and molecular drivers of cardiovascular disease, advancing programs into the clinic to pursue durable, disease‑modifying approaches. Lexeo’s mission is to fundamentally change how cardiovascular conditions are treated by applying pioneering science to deliver new therapeutic options.
Recent company news
Yahoo FinanceLexeo Therapeutics to Participate in the Leerink Global Healthcare Conference
2 weeks ago
GlobeNewswireLexeo Therapeutics Announces Closing of Public Offering and
Oct 20, 2025
MarketBeatLexeo Therapeutics Highlights FA and PKP2 Cardiac Gene Therapy Progress at Oppenheimer Conference
2 weeks ago
Seeking AlphaLexeo Therapeutics: Behind The Rebound (NASDAQ:LXEO)
Nov 6, 2025
Investing.comLexeo Therapeutics stock falls after PKP2 gene therapy data
Jan 12, 2026
About Lexeo Therapeutics
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Lexeo Therapeutics.
Salary
$120k – $150k
per year